Physician profile
Robin Zagone
NPI 1023192960
$464.60
in general payments reported to CMS, 2019-2025
10 companies · $50.00 in 2025
The $50.00 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.25 · 2020: $76.17 · 2021: $15.53 · 2022: $138 · 2023: $80.85 · 2024: $77.50 · 2025: $50.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $208.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $144.00 | 2023-2024 | Erleada, Akeega, Balversa |
| Neotract INC. | $76.17 | 2020 | |
| Boston Scientific Corporation | $63.25 | 2019-2022 | |
| Pfizer INC. | $50.00 | 2025 | |
| Allergan, INC. | $32.78 | 2019-2022 | |
| Myovant Sciences INC. | $31.08 | 2022 | |
| Janssen Biotech, INC. | $23.61 | 2022 | |
| Urogen Pharma, INC. | $15.53 | 2021 | |
| Srs Medical Systems, INC. | $14.35 | 2023 | Urocuff |
| Endo Pharmaceuticals INC. | $13.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Zagone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.